COLCHICINE
Clinical trials for COLCHICINE explained in plain language.
Never miss a new study
Get alerted when new COLCHICINE trials appear
Sign up with your email to follow new studies for COLCHICINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cheap arthritis drug prevent second strokes and disability?
Disease control Not yet recruitingThis study tests whether a low-dose daily pill called colchicine can help people recover better and avoid future heart attacks or strokes after a brain hemorrhage. About 1,125 adults who have had a brain bleed and also have signs of artery disease will take either colchicine or a…
Matched conditions: COLCHICINE
Phase: PHASE3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Can a common gout drug slow heart disease in people with a gene variant?
Disease control Not yet recruitingThis study tests whether colchicine, a drug used for gout, can slow the buildup of plaque in heart arteries. It includes 120 adults aged 40-85 who recently had a heart attack and have a specific gene variant (TET2-CHIP). Researchers will measure plaque changes using CT scans over…
Matched conditions: COLCHICINE
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Heart bypass patients may benefit from cheap gout drug to keep grafts open
Disease control Not yet recruitingThis study tests whether taking a low dose of colchicine (0.5 mg daily) after coronary artery bypass grafting (CABG) can reduce the chance of graft failure. About 622 adults who recently had bypass surgery will receive either colchicine or a placebo for 24 months. The main goal i…
Matched conditions: COLCHICINE
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 18, 2026 12:09 UTC